what are the Recommendations for the Management of Comorbidities in Patients
With HF
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients with HF and anemia, erythropoietin- stimulating agents should not be used to improve morbidity and mortality.